Company Filing History:
3 out of 9 
1 out of 13 
1 out of 257 
Years Active: 2013-2017
Title: Takayuki Ishige: Innovator in Pharmaceutical Chemistry
Introduction
Takayuki Ishige is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel crystalline forms of compounds. With a total of five patents to his name, Ishige's work has implications for therapeutic applications.
Latest Patents
Ishige's latest patents include the crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate. He has also developed Crystalline Forms I and II of the same compound, along with compositions, methods of manufacture, and therapeutic uses thereof. These innovations are crucial for enhancing the efficacy and stability of pharmaceutical formulations.
Career Highlights
Throughout his career, Ishige has worked with notable companies such as Forum Pharmaceuticals, Inc. and Envivo Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise in drug development and patenting processes.
Collaborations
Ishige has collaborated with esteemed colleagues, including Patricia Oliver-Shaffer and Gideon Shapiro. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Takayuki Ishige's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the industry. His work continues to influence the development of effective therapeutic agents.